01 8Gowling Lafleur Henderson LLP
02 6Gowling WLG (Canada) LLP
01 72401033
02 22715685
03 52747395
01 14BRIVARACETAM
01 4SOLUTION
02 10TABLET
01 72021-02-21
02 22029-03-02
03 52030-01-27
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Brand Name : BRIVLERA
Patent Number : 2401033
Filing Date : 2001-02-21
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Brand Name : BRIVLERA
Patent Number : 2401033
Filing Date : 2001-02-21
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Brand Name : BRIVLERA
Patent Number : 2401033
Filing Date : 2001-02-21
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Brand Name : BRIVLERA
Patent Number : 2401033
Filing Date : 2001-02-21
Strength per Unit : 75 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Brand Name : BRIVLERA
Patent Number : 2401033
Filing Date : 2001-02-21
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Patent Expiration Date : 2029-03-02
Date Granted : 2015-04-28
Brand Name : BRIVLERA
Patent Number : 2715685
Filing Date : 2009-03-02
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2029-03-02
Date Granted : 2015-04-28
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Brand Name : BRIVLERA
Patent Number : 2401033
Filing Date : 2001-02-21
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Brand Name : BRIVLERA
Patent Number : 2401033
Filing Date : 2001-02-21
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-21
Date Granted : 2008-07-29
Patent Expiration Date : 2030-01-27
Date Granted : 2015-01-13
Brand Name : BRIVLERA
Patent Number : 2747395
Filing Date : 2010-01-27
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-01-27
Date Granted : 2015-01-13
Patent Expiration Date : 2030-01-27
Date Granted : 2015-01-13
Brand Name : BRIVLERA
Patent Number : 2747395
Filing Date : 2010-01-27
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-01-27
Date Granted : 2015-01-13
